» Articles » PMID: 20219929

Array-based Transcript Profiling and Limiting-dilution Reverse Transcription-PCR Analysis Identify Additional Latent Genes in Kaposi's Sarcoma-associated Herpesvirus

Overview
Journal J Virol
Date 2010 Mar 12
PMID 20219929
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a B-lymphotropic herpesvirus strongly linked to both lymphoproliferative diseases and Kaposi's sarcoma. The viral latency program of KSHV is central to persistent infection and plays important roles in the pathogenesis of KSHV-related tumors. Up to six polypeptides and 18 microRNAs are known to be expressed in latency, but it is unclear if all major latency genes have been identified. Here, we have employed array-based transcript profiling and limiting-dilution reverse transcription-PCR (RT-PCR) methodologies to explore this issue in several KSHV-infected cell lines. Our results show that RNAs encoding the K1 protein are found at low levels in most latently infected cell lines. The gene encoding v-IL-6 is also expressed as a latent transcript in some contexts. Both genes encode powerful signaling molecules with particular relevance to B cell biology: K1 mimics signaling through the B cell receptor, and v-IL-6 promotes B cell survival. These data resolve earlier controversies about K1 and v-IL-6 expression and indicate that, in addition to core latency genes, some transcripts can be expressed in KSHV latency in a context-dependent manner.

Citing Articles

Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases.

Losay V, Damania B Viruses. 2025; 17(2).

PMID: 40006930 PMC: 11860327. DOI: 10.3390/v17020177.


The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis.

Komaki S, Inagaki T, Kumar A, Izumiya Y Viruses. 2025; 16(12.

PMID: 39772207 PMC: 11680145. DOI: 10.3390/v16121900.


FoxK1 and FoxK2 cooperate with ORF45 to promote late lytic replication of Kaposi's sarcoma-associated herpesvirus.

Chen Q, Li X, Quan L, Zhou R, Liu X, Cheng L J Virol. 2024; 98(12):e0077924.

PMID: 39494902 PMC: 11650984. DOI: 10.1128/jvi.00779-24.


Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection.

Li S, Wang M, Van Sciver N, Szymula A, Tumuluri V, George A PLoS Pathog. 2024; 20(1):e1011907.

PMID: 38232124 PMC: 10793894. DOI: 10.1371/journal.ppat.1011907.


KSHV 3.0: a state-of-the-art annotation of the Kaposi's sarcoma-associated herpesvirus transcriptome using cross-platform sequencing.

Prazsak I, Tombacz D, Fulop A, Torma G, Gulyas G, Dormo A mSystems. 2024; 9(2):e0100723.

PMID: 38206015 PMC: 10878076. DOI: 10.1128/msystems.01007-23.


References
1.
Jenner R, Boshoff C . The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta. 2002; 1602(1):1-22. DOI: 10.1016/s0304-419x(01)00040-3. View

2.
Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B . A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol. 1999; 73(7):5722-30. PMC: 112632. DOI: 10.1128/JVI.73.7.5722-5730.1999. View

3.
Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore P . Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science. 2002; 298(5597):1432-5. DOI: 10.1126/science.1074883. View

4.
Bowser B, DeWire S, Damania B . Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J Virol. 2002; 76(24):12574-83. PMC: 136681. DOI: 10.1128/jvi.76.24.12574-12583.2002. View

5.
Spiller O, Robinson M, ODonnell E, Milligan S, Morgan B, Davison A . Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J Virol. 2002; 77(1):592-9. PMC: 140610. DOI: 10.1128/jvi.77.1.592-599.2003. View